Optimising bloodless cardiovascular surgery for Jehovah's Witnesses and beyond

Jubouri, Matti, Hedayat, Fatemeh, Abrar, Sakina, Mellor, Sophie L, Brown, Louise J and Harky, Amer (2021) Optimising bloodless cardiovascular surgery for Jehovah's Witnesses and beyond. Coronary Artery Disease . ISSN 0954-6928

Full text not available from this repository.

Official URL: https://doi.org/10.1097/MCA.0000000000001050


Emerging evidence suggests surgical outcomes of patients undergoing cardiovascular surgery that refuse autologous transfusion is comparable to those who accept whole blood product transfusions. There are several methods that can be used to minimize blood loss during cardiovascular surgery. These methods can be categorised into pharmacological measures, including the use of erythropoietin, iron and tranexamic acid, surgical techniques, like the use of polysaccharide haemostat, and devices such as those used in acute normovolaemic haemodilution. More prospective studies with stricter protocols are required to assess surgical outcomes in bloodless cardiac surgery as well as further research into the long-term outcomes of bloodless cardiovascular surgery patients. This review summarizes current evidence on the use of pre-, intra-, and post-operative strategies aimed at the subset of patients who refuse blood transfusion, for example Jehovah's Witnesses. [Abstract copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.]

Repository Staff Only: item control page